Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Organs at risk radiation dose constraints
Abstract
Dose constraints are essential for performing dosimetry, especially for intensity modulation and for radiotherapy under stereotaxic conditions. We present the update of the recommendations of the French society of oncological radiotherapy for the use of these doses in classical current practice but also for reirradiation.
Source and rights
Published by Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2022. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2022
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
- PubMed
- 34953713
- Added to Prognia
- 22 July 2026
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
